Risperidone

This publication has 94 references indexed in Scilit:

• Some Aspects of the Cost of Schizophrenia in France
  PharmacoEconomics, 1997
• Economic outcomes and costs in the treatment of schizophrenia
  Clinical Therapeutics, 1997
• Risperidone: How Good Is the Evidence for Efficacy?
  Schizophrenia Bulletin, 1997
• The use of risperidone in treatment-resistant schizophrenia
  International Clinical Psychopharmacology, 1996
• Risperidone in the Treatment of Children and Adolescents with Schizophrenia: A Retrospective Study
  Journal of Child and Adolescent Psychopharmacology, 1996
• Risperidone response after no clozapine response
  The British Journal of Psychiatry, 1995
• Measuring the Costs of Schizophrenia
  PharmacoEconomics, 1995
• Effects of Limiting Medicaid Drug-Reimbursement Benefits on the Use of Psychotropic Agents and Acute Mental Health Services by Patients with Schizophrenia
  New England Journal of Medicine, 1994
• Methods for evaluation of the direct and indirect costs of long-term schizophrenia
  Acta Psychiatrica Scandinavica, 1994
• A Report of Clozapine† - Induced Agranulocytosis in the United States
  Drug Safety, 1992